Dr Lalchandani Labs
DLCLBSE

Dr Lalchandani Labs

₹9.700.00 (0.00%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
9.70
Today’s high
9.70
52 week low
8.15
52 week high
21.22
Open price
9.70
Previous close
9.70
Live volume
--
Lower circuit
9.22
Upper circuit
10.18

Fundamentals

Market Cap
₹8.41Cr
ROE
4.53%
P/E Ratio(TTM)
20.21
EPS(TTM)
0.48
P/B Ratio
0.59
Dividend Yield
0.00%
Industry P/E
80.43
Book Value
16.49
Debt to Equity
0.45
Face Value
10

Financial performance

Quarterly
Yearly
All Financials
2025
Revenue (Cr)
₹4.46
-11.57%
Profit (Cr)
₹0.42
-32.44%
-5051015
2021
2022
2023
2024
2025
Revenue growthValue
3Y CAGR-27%
Profit growthValue
3Y CAGR-24%

About

Dr Lalchandani Labs Limited is a NABL accredited company that operates laboratories for a wide range of pathological and diagnostic investigations in Delhi/NCR. The company's vision is to become one of the top listed laboratories in the country offering pathology and diagnostic services within the next five years. It is built on a strong belief in fulfilling its commitments by making sincere efforts to execute its plans and strategies to serve its customers. Its core business involves running labs to conduct tests in branches like Bio-Chemistry, Hematology, Microbiology, Virology, and DNA & Genetic Testing for patients and hospitals. Unlike in developed markets, the diagnostic business in India is primarily a Business-to-Consumer (B2C) model where patients directly approach labs for testing. The company has established a network of 5 self-sufficient labs and 15 collection centers strategically located across the Delhi/NCR region to ensure accessibility.;
CEO/MD
Mr. Mohit Lalchandani
Founded in
1986
BSE symbol
541299

Shareholding Pattern

Mar '24
Sep '24
Mar '25
Sep '25
Mar '26
Retail And Others
67.10%
Promoters
32.90%
2026

27
Jan
Rights Entitlement
Ex date
1:1
Ratio

1 rights eligible for every 1 existing shares held
Ratio1:1
Offer price₹10.00
Ex date27 Jan ‘26
Record date27 Jan ‘26
Announcement date20 Jan ‘26

20
Jan
Rights Entitlement
Announced
1:1
Ratio

1 rights eligible for every 1 existing shares held
Ratio1:1
Offer price₹10.00
Ex date27 Jan ‘26
Record date27 Jan ‘26
Announcement date20 Jan ‘26
2025
14
Nov
Result
Release date
Events calendar
View upcoming events in other stocks